Open AccessNeoadjuvant Docetaxel Plus Carboplatin Versus Epirubicin Plus Cyclophosphamide Followed by Docetaxel in Triple-Negative, Early-Stage Breast Cancer
Author(s) -
Rana Atique Anwer,
Sajid Ghafor,
Huma Ahmad
Publication year - 2022
Publication title -
pakistan journal of medical and health sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.114
H-Index - 7
ISSN - 1996-7195
DOI - 10.53350/pjmhs22168356
Subject(s) - docetaxel , medicine , epirubicin , carboplatin , regimen , oncology , breast cancer , chemotherapy , taxane , cyclophosphamide , triple negative breast cancer , anthracycline , cancer , cisplatin
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom